COMPANY NAME    SYMBOL     : BM DATE    : BM PURPOSE
Solex Energy Limited SOLEX : 18-JUN-2026 : Dividend To consider dividend
Univastu India Limited UNIVASTU : 19-JUN-2026 : Fund Raising To consider Fund Raising
Bharati Defence and Infrastructure Limited BHARATIDIL : 17-JUN-2026 : Other business matters To consider and approve the proposed Scheme of Merger/Amalgamation involving Exicom Technologies India Private Limited and Hind Simulation Training Private Limited with Bharati Defence and Infrastructure Limited and matters incidental thereto
Ganga Forging Limited GANGAFORGE : 16-JUN-2026 : Fund Raising To consider Fund Raising
AVATAR Industries Limited AVATAR : 17-JUN-2026 : Other business matters To consider and approve the Migration of the Company s present listing/trading of Equity Shares from SME Platform of NSE Limited (NSE-EMERGE) to Main Board of NSE Limited.
Ansal Properties & Infrastructure Limited ANSALAPI : 17-JUN-2026 : Financial Results/Dividend To consider and approve the final Dividend FY 2024-25 and financial results for the period:

i.	03rd Quarter ended on the 31st December, 2024 (subjected to Limited Review Report) (Standalone and Consolidated), 
ii.	04th Quarter/Year ended on the 31st March, 2025 (Subjected to Auditors Report) (Standalone and Consolidated),
iii.	01st Quarter ended on the 30th June, 2025, (subjected to Limited Review Report) (Standalone),
iv.	02nd Quarter/Half Year ended on the 30th September, 2025 (subjected to Limited Review Report) (Standalone),
v.	03rd Quarter ended on the 31st December, 2025 (subjected to Limited Review Report) (Standalone).
Tata Capital Limited TATACAP : 17-JUN-2026 : Fund Raising To consider the proposal for issuance of Non-Convertible Debentures, on a private placement basis, in one or more tranches, subject to approval of the Shareholders.
Finkurve Financial Services Limited FINKURVE : 15-JUN-2026 : Fund Raising To consider Fund Raising
Q-Line Biotech Limited QLINE : 17-JUN-2026 : Financial Results/Other business matters inter alia, 
1.	To consider and approve the Standalone & Consolidated Audited Financial Results of the Company for the Financial Year ended 31st March, 2026 along with the Statement of Assets and Liabilities as on that date and Cash Flow Statement for the financial year ended 31st March, 2026 and to take on record Auditor s Report thereon by the Statutory Auditors of the Company.

2.	To Consider and Approve the Internal Audit Report of the Company.

3.	Any other business with permission of the Chair, if any.
